HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALEBUND-B

25.000

-0.740-2.87%

Volume:772.70K

Turnover:19.59M

Market Cap:8.70B

PE:-8.14

High:26.960

Open:26.960

Low:24.500

Close:25.740

52wk High:46.820

52wk Low:22.720

Shares:348.00M

HK Float Shares:236.00M

Volume Ratio:0.60

T/O Rate:0.33%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-3.071

ROE:--

ROA:-33.01%

PB:5.28

PE(LYR):-8.14

PS:60.68

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Alebund Pharmaceuticals (Jiangsu) Says IND Application for AP308 Cleared by U.S. FDA

ALEBUND-B Wins US FDA Nod to Start Trial of Novel IgA Nephropathy Drug AP308

Alebund Pharmaceuticals (Jiangsu) - AP308 Clinical Trial Planned Soon Following FDA Ind Clearance

THOMSON REUTERS

Alebund Pharma Wins US FDA Clearance to Start AP308 IgA Nephropathy Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/09637"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"09637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","market":"HK","secType":"STK","nameCN":"ALEBUND-B","latestPrice":25,"timestamp":1789027722352,"preClose":25.74,"halted":0,"volume":772700,"delay":0,"changeRate":-0.02874902874902869,"floatShares":236000000,"shares":348000000,"eps":-3.071284,"marketStatus":"Closed","change":-0.74,"latestTime":"09-10 16:08:42","open":26.96,"high":26.96,"low":24.5,"amount":19587070,"amplitude":0.095571,"askPrice":25.1,"askSize":800,"bidPrice":25,"bidSize":700,"shortable":0,"etf":0,"ttmEps":-2.326,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1782662400000,"exchange":"SEHK","adjPreClose":25.74,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.600411,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","floatShares":236000000,"roa":"-33.01%","roe":"--","lyrEps":-3.071284,"volumeRatio":0.600411,"shares":348000000,"dividePrice":0,"high":26.96,"amplitude":0.095571,"preClose":25.74,"low":24.5,"week52Low":22.72,"pbRate":"5.28","psRate":"60.68","week52High":46.82,"institutionHeld":0,"latestPrice":25,"committee":-0.066667,"eps":-3.071284,"divideRate":0,"volume":772700,"delay":0,"ttmEps":-2.326,"open":26.96,"prevYearClose":22.6,"prevWeekClose":28.8,"prevMonthClose":31.48,"prevQuarterClose":45.92,"fiveDayClose":28.5,"twentyDayClose":34.06,"sixtyDayClose":22.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09637\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"09637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09637\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":3,"updateTime":1787846400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09637","date":"2026-09-09","current":-10.748065,"percent":0.882353,"low":-18.066068,"twenty":-12.955062,"median":-11.803166,"eighty":-10.916271,"high":-8.42626,"avg":-12.01212,"sd":1.735082,"marketCap":8747796425},"quantilePoints":[{"date":"2026-06-26","current":-8.87585,"twenty":-8.87585,"median":-8.87585,"eighty":-8.87585,"marketCap":7680660420},{"date":"2026-07-03","current":-11.883178,"twenty":-18.03155,"median":-11.883178,"eighty":-9.78101,"marketCap":10290725554},{"date":"2026-07-10","current":-12.164969,"twenty":-13.966639,"median":-11.847257,"eighty":-11.12129,"marketCap":10521825071},{"date":"2026-07-17","current":-10.947234,"twenty":-12.322489,"median":-11.455859,"eighty":-10.783874,"marketCap":9502268378},{"date":"2026-07-24","current":-11.320561,"twenty":-11.939536,"median":-11.377389,"eighty":-10.939493,"marketCap":9828526520},{"date":"2026-07-31","current":-10.642718,"twenty":-11.840073,"median":-11.194259,"eighty":-10.78337,"marketCap":9257574772},{"date":"2026-08-07","current":-12.743391,"twenty":-12.396338,"median":-11.399787,"eighty":-10.889159,"marketCap":11106370909},{"date":"2026-08-14","current":-13.03884,"twenty":-12.987078,"median":-11.462395,"eighty":-10.903987,"marketCap":11378252693},{"date":"2026-08-21","current":-12.870195,"twenty":-13.077865,"median":-11.725167,"eighty":-10.931752,"marketCap":11255905890},{"date":"2026-08-28","current":-12.144658,"twenty":-13.077865,"median":-11.990608,"eighty":-10.959851,"marketCap":10623780741},{"date":"2026-09-04","current":-11.919154,"twenty":-12.988947,"median":-11.883178,"eighty":-10.931752,"marketCap":9787744252},{"date":"2026-09-09","current":-10.635722,"twenty":-12.955062,"median":-11.803166,"eighty":-10.916271,"marketCap":8747796425}],"updateTime":1789030593269},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09637\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665431379","title":"Alebund Pharmaceuticals (Jiangsu) Says IND Application for AP308 Cleared by U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2665431379","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665431379?lang=en_us&edition=fundamental","pubTime":"2026-09-08 23:31","pubTimestamp":1788881494,"startTime":"0","endTime":"0","summary":"Sept 8 (Reuters) - Alebund Pharmaceuticals (Jiangsu) Ltd <9637.HK>::*INVESTIGATIONAL NEW DRUG APPLICATION FOR AP308 FOR TREATMENT OF IGA NEPHROPATHY CLEARED BY U.S. FDA*Further company coverage: 9637.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nRSDYgyKG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141807270","title":"ALEBUND-B Wins US FDA Nod to Start Trial of Novel IgA Nephropathy Drug AP308","url":"https://stock-news.laohu8.com/highlight/detail?id=1141807270","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141807270?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:06","pubTimestamp":1788869176,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for AP308, a first-in-class engineered recombinant IgA...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","IBBJ","BK1191","09637","BK1515","PSYK","BK1161","159938","MDTX","159151","09939","BMED","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665416320","title":"Alebund Pharmaceuticals (Jiangsu) - AP308 Clinical Trial Planned Soon Following FDA Ind Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2665416320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665416320?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:05","pubTimestamp":1788869101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA2NDWZM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665132055","title":"Alebund Pharma Wins US FDA Clearance to Start AP308 IgA Nephropathy Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665132055","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665132055?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868895,"startTime":"0","endTime":"0","summary":"Alebund Pharma wins US FDA clearance to start AP308 IgA nephropathy trialAlebund Pharmaceuticals (Jiangsu) secured FDA clearance for an IND for AP308 in IgA nephropathy.Approval enables the start of a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL3brvHr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":17,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/09637\",params:#limit:6,delay:false,,,undefined,":[]}}